• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国成年人非酒精性脂肪性肝病与死亡率之间的关联分析。

Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults.

作者信息

Rong Fen, Mai Yiyi, Shou Lujia, Zhu Xinya, Li Meiyue, Zhu Liuchen, Sun Xiuli, Zhao Xinhua

机构信息

School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Nutr. 2024 Nov 22;11:1502671. doi: 10.3389/fnut.2024.1502671. eCollection 2024.

DOI:10.3389/fnut.2024.1502671
PMID:39650715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620881/
Abstract

BACKGROUND

Non-alcoholic Fatty Liver Disease (NAFLD) is a prevalent condition characterized by the accumulation of fat in the liver, often linked with increased risk for multi-systemic diseases. This study aims to investigate the relationship between NAFLD and mortality, particularly all-cause and cardiovascular mortality, among United States adults.

METHODS

Data from the National Health and Nutrition Examination Survey (NHANES) were utilized, encompassing 80,312 participants from 2003-2004 to 2017-2018. After exclusions for incomplete data, potential other liver diseases, and significant alcohol consumption, the final analytical cohort included 32,698 participants. The Fatty Liver Index (FLI), a non-invasive diagnostic tool, was used to identify NAFLD. Covariates included demographic characteristics, lifestyle factors, and biochemical parameters. Survival analysis was conducted using a weighted Cox proportional hazards regression model to quantify the impact of NAFLD on mortality.

RESULTS

The study revealed that NAFLD was significantly associated with increased risks of all-cause and cardiovascular disease (CVD) mortality. The hazard ratios (HRs) from the survival analysis consistently indicated a higher risk among participants with NAFLD compared to those without. Subgroup analyses further confirmed the association, with notable exceptions in certain subgroups such as those with high school education and diabetes. Additionally, a nonlinear relationship between serum uric acid (SUA) levels and mortality risk was identified among NAFLD participants.

CONCLUSION

Non-alcoholic Fatty Liver Disease is a significant risk factor for all-cause and CVD mortality in US adults. The findings underscore the importance of early detection and intervention for NAFLD to mitigate its impact on public health. Further research is needed to explore the complex interactions between NAFLD, SUA levels, and mortality, particularly in high-risk subgroups.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种常见病症,其特征为肝脏中脂肪堆积,常与多系统疾病风险增加相关。本研究旨在调查美国成年人中NAFLD与死亡率之间的关系,尤其是全因死亡率和心血管疾病死亡率。

方法

利用美国国家健康与营养检查调查(NHANES)的数据,涵盖了2003 - 2004年至2017 - 2018年的80312名参与者。在排除数据不完整、潜在的其他肝脏疾病以及大量饮酒情况后,最终分析队列包括32698名参与者。使用非侵入性诊断工具脂肪肝指数(FLI)来识别NAFLD。协变量包括人口统计学特征、生活方式因素和生化参数。采用加权Cox比例风险回归模型进行生存分析,以量化NAFLD对死亡率的影响。

结果

研究表明,NAFLD与全因死亡率和心血管疾病(CVD)死亡率风险增加显著相关。生存分析得出的风险比(HRs)始终表明,患有NAFLD的参与者比未患NAFLD的参与者风险更高。亚组分析进一步证实了这种关联,但在某些亚组中存在显著例外,如高中学历者和糖尿病患者。此外,在NAFLD参与者中发现血清尿酸(SUA)水平与死亡风险之间存在非线性关系。

结论

非酒精性脂肪性肝病是美国成年人全因死亡率和CVD死亡率的重要危险因素。这些发现强调了早期发现和干预NAFLD以减轻其对公众健康影响的重要性。需要进一步研究来探索NAFLD、SUA水平和死亡率之间的复杂相互作用,特别是在高危亚组中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/81df4e164fe2/fnut-11-1502671-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/0980d412a858/fnut-11-1502671-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/42ac5bfd38f6/fnut-11-1502671-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/926b7593ed5f/fnut-11-1502671-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/3117afc2aead/fnut-11-1502671-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/9396412d5ccf/fnut-11-1502671-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/81df4e164fe2/fnut-11-1502671-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/0980d412a858/fnut-11-1502671-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/42ac5bfd38f6/fnut-11-1502671-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/926b7593ed5f/fnut-11-1502671-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/3117afc2aead/fnut-11-1502671-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/9396412d5ccf/fnut-11-1502671-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aed/11620881/81df4e164fe2/fnut-11-1502671-g006.jpg

相似文献

1
Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults.美国成年人非酒精性脂肪性肝病与死亡率之间的关联分析。
Front Nutr. 2024 Nov 22;11:1502671. doi: 10.3389/fnut.2024.1502671. eCollection 2024.
2
Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成人患者血清尿酸与全因死亡率和心血管死亡率的关联
Clin Endocrinol (Oxf). 2023 Jan;98(1):49-58. doi: 10.1111/cen.14810. Epub 2022 Aug 22.
3
The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients.血清尿酸水平与非酒精性脂肪性肝病患者 10 年心血管疾病风险的关系。
Int J Environ Res Public Health. 2022 Jan 18;19(3):1042. doi: 10.3390/ijerph19031042.
4
Dietary folate intake and all-cause mortality and cardiovascular mortality in American adults with non-alcoholic fatty liver disease: Data from NHANES 2003 to 2018.膳食叶酸摄入与美国非酒精性脂肪性肝病成人的全因死亡率和心血管死亡率:来自 NHANES 2003 至 2018 年的数据。
PLoS One. 2024 Nov 21;19(11):e0314148. doi: 10.1371/journal.pone.0314148. eCollection 2024.
5
Association Between High Sensitivity Cardiac Troponin and All-Cause and Cardiovascular Mortality in Adults at Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.高敏心肌肌钙蛋白与有非酒精性脂肪性肝病风险的成年人全因死亡率和心血管死亡率之间的关联:一项队列研究
Glob Heart. 2025 Apr 29;20(1):40. doi: 10.5334/gh.1427. eCollection 2025.
6
Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis.评估非酒精性脂肪性肝病、代谢功能障碍性脂肪性肝病和代谢功能障碍相关肝病之间的死亡率差异:一项综合荟萃分析。
Cureus. 2024 Oct 16;16(10):e71639. doi: 10.7759/cureus.71639. eCollection 2024 Oct.
7
Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction.血清尿酸与肝、肾疾病及心肌梗死后 12 年的死亡风险相关。
Front Endocrinol (Lausanne). 2023 Oct 11;14:1240099. doi: 10.3389/fendo.2023.1240099. eCollection 2023.
8
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.高血压在非酒精性脂肪性肝病中普遍存在,并增加全因死亡率和心血管疾病死亡率。
Front Cardiovasc Med. 2022 Aug 8;9:942753. doi: 10.3389/fcvm.2022.942753. eCollection 2022.
9
Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease.生活方式改变与非酒精性脂肪性肝病患者全因、心血管和过早死亡的关系。
Nutrients. 2024 Jun 28;16(13):2063. doi: 10.3390/nu16132063.
10
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.肌肉减少症和身体活动不足对非酒精性脂肪性肝病患者死亡率的影响。
JHEP Rep. 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171. eCollection 2020 Dec.

本文引用的文献

1
Associations of daily eating frequency and nighttime fasting duration with biological aging in National Health and Nutrition Examination Survey (NHANES) 2003-2010 and 2015-2018.每日进食频率和夜间禁食持续时间与 2003-2010 年和 2015-2018 年国家健康和营养检查调查(NHANES)中生物衰老的关联。
Int J Behav Nutr Phys Act. 2024 Sep 19;21(1):104. doi: 10.1186/s12966-024-01654-y.
2
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.NAFLD 患者甘油三酯-葡萄糖相关参数与全因死亡率和心血管疾病的关系:NHANES 1999-2018。
Cardiovasc Diabetol. 2024 Jul 18;23(1):262. doi: 10.1186/s12933-024-02354-4.
3
Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease.
非酒精性脂肪性肝病患者的血清尿酸水平与预后
Sci Rep. 2024 Mar 11;14(1):5923. doi: 10.1038/s41598-024-55845-5.
4
Analysis of the association between urinary glyphosate exposure and fatty liver index: a study for US adults.分析尿中草甘膦暴露与脂肪肝指数的关联性:一项针对美国成年人的研究。
BMC Public Health. 2024 Mar 5;24(1):703. doi: 10.1186/s12889-024-18189-3.
5
The prognostic role of diet quality in patients with MAFLD and physical activity: data from NHANES.饮食质量对 MAFLD 患者和体力活动的预后作用:来自 NHANES 的数据。
Nutr Diabetes. 2024 Feb 23;14(1):4. doi: 10.1038/s41387-024-00261-x.
6
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.非酒精性脂肪性肝病与 2 型糖尿病患者心血管疾病及全因死亡的相关性:全国范围内基于人群的研究。
BMJ. 2024 Feb 13;384:e076388. doi: 10.1136/bmj-2023-076388.
7
Dietary Niacin Intake and Mortality Among Individuals With Nonalcoholic Fatty Liver Disease.饮食烟酸摄入与非酒精性脂肪性肝病患者的死亡率。
JAMA Netw Open. 2024 Feb 5;7(2):e2354277. doi: 10.1001/jamanetworkopen.2023.54277.
8
Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.美国成年人中NAFLD、MAFLD和MASLD的特征及死亡率结果比较。
Liver Int. 2024 Apr;44(4):1051-1060. doi: 10.1111/liv.15856. Epub 2024 Jan 31.
9
Race and ethnic differences in physical activity, osteopenia, and osteoporosis: results from NHANES 2009-2010, 2013-2014, 2017-2018.种族和民族差异与身体活动、低骨量和骨质疏松症:来自 NHANES 2009-2010、2013-2014、2017-2018 的结果。
Arch Osteoporos. 2023 Dec 27;19(1):7. doi: 10.1007/s11657-023-01356-1.
10
From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病:脂肪性肝病的更新命名及诊断标准
J Lipid Res. 2024 Jan;65(1):100485. doi: 10.1016/j.jlr.2023.100485. Epub 2023 Dec 14.